Evaluation of sulfated lentinus edodes α-(1→3)-d-glucan as a potential antitumor agent

Bioscience, Biotechnology and Biochemistry

Volumn 66, Issue 5, 2002, Pages 1052-1056

  Zhang, Pingyi ^a   Cheung, Peter C K ^b  

^a PURDUE UNIVERSITY   (United States)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antitumor activity; Lentinus edodes; Molecular weight; Sulfated derivative; (1 3) D glucan

Indexed keywords

LENTINULA EDODES; LENTINUS; MINK CELL FOCUS-FORMING VIRUS; MURINAE;

ANTINEOPLASTIC AGENT; GLUCAN; SULFATE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL CULTURE; CELL DIVISION; CHEMISTRY; DRUG EFFECT; DRUG SCREENING; EVALUATION; HUMAN; LENTINUS; MALE; MOUSE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; DRUG SCREENING ASSAYS, ANTITUMOR; GLUCANS; HUMANS; LENTINULA; MALE; MICE; MICE, INBRED BALB C; SULFATES; TUMOR CELLS, CULTURED;

EID: 0036562411     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.66.1052     Document Type: Article

References (32)

1. Mizuno, M., Morimoto, M., Minato, K., and Tsuchida, H., Polysaccharides fromAgaricus blazeistimulate lymphocyte T-cell subsets in mice.Biosci. Biotechnol. Biochem.,62, 434-437 (1998).
2. Chihara, G., Maeda, Y., Hamuro, J., Sasaki, T., and Fukuoka, F., Inhibition of mouse sarcoma 180 by polysaccharides fromLentinus edodes. Nature,222, 687-688 (1969).
3. Maeda, Y. Y. and Chihara, G., Lentinan, a new im-muno-acclerator of cell-mediated responses.Nature, 229, 634-638 (1971).
4. Whistler, R. L., Bushway, A. A., Singh, P. P., Nakahara, W., and Tokuzen, R., Noncytotoxic, antitumor polysaccharides.Adv. Carbohydr. Chem. Biochem.,32, 235-275 (1976).
5. Sasaki, T. and Takasuka, N., Further study of the structure of lentinan, an anti-tumor polysaccharide fromLentinus edodes. Carbohydr. Res.,47, 99-105 (1976).
6. Kawagishi, H., Inagaki, R., Kanao, T., Mizuno, T., Shimura, K., Ito, H., Hagiwara, T., and Nakamura, T., Fractionation and antitumor activity of the water-insoluble residue ofAgaricus blazeifruiting bodies.Carbohydr. Res.,186, 267-273 (1989).
7. Mizuno, T., Ando, M., Sugie, R., Ito, H., Shimura, K., Shimiya, T., and Matsuura, A., Antitumor activity of some polysaccharides isolated from an edible mushroom, ningyotake, the fruiting body and the cultured mycelium ofPolyporous confluents. Biosci. Biotechnol. Biochem.,56, 34-41 (1992).
8. Mizuno, T., The extraction and development of antitumor-active polysaccharides from medicinal mushrooms in Japan.Intern. J. Med. Mush.1, 9-29, (1999).
9. Bohn, J. A. and BeMiller, J. N., (1→3)-β-D-glucans as biological response modifiers: A review of structure-functional activity relationships.Carbohydr. Polymers.28, 3-14 (1995).
10. Tanigami, Y., Kusumoto, S., Nagao, S., Kokeguchi, S., Kato, K., Kotani, S. and Shiba, T., Partial degradation and biological activities of an antitumor polysaccharide from rice bran.Chem. Pharm. Bull.,39, 1782-1787 (1991).
11. Mizuno, T., Saito, H., Nishitoba, T., and Kawagishi, H., Antitumor-active substances from mushrooms.Food Rev. Intern.,11, 23-61 (1995).
12. Shida, M., Hargu, K., and Matsuda, K., On the water-soluble heterogalactan from the fruit bodies ofLentinus edodes. Carbohydr. Res.,41, 211-218 (1975).
13. Shida, M., Uchida, T., and Matsuda, K., A (1β3)-α-D-glucan isolated from the fruit bodies ofLentinus edodes. Carbohydr. Res.,60, 117-127 (1978).
14. Zhang, P., Zhang, L., and Cheng, S., Chemical Structure and Molecular Weights of a-(1-3)-D-Glucan fromLentinus edodes. Biosci. Biotechnol. Biochem.,63, 1197-1202 (1999).
15. Suzuki, T., Ohno, N., Adachi, Y., Cirelli, A. F., Covian, J. A., and Yadomae, T., Preparation and biological-activities of sulfated derivatives of (1→3)-β-D-glucans.J. Pharmacobio-Dyn.,14, 256-266 (1991).
16. Williams, D. L., Pretus, H. A., McNamee, R. B., Jones, E. L., Ensley, H. E., and Browder I. W., Development of a water-soluble, sulfated (1→3)-β-glucan biological response modifier derived fromSaccharomyces-cerevisiae. Carbohydr. Res.,235, 247-257 (1992).
17. Demleitner, S., Kraus, J., Franz, G., Synthesis and antitumor-activity of sulfoalkyl derivatives of curdlan and lichenan.Carbohydr. Res.,226, 247-252 (1992).
18. Kiho, T., Yoshida, I., Nagai, K., Ukai, S., and Hara, C., Polysaccharides in fungi a-(1^3)-D-glucan from an alkaline extract ofAgrocybe cylindracea, and antitumor-activity of its O-(carboxymethyl)ated derivatives.Carbohydr. Res.,189, 273-279 (1989).
19. Chihara, G., Immunopharmacology of Lentinan, a polysaccharide isolated fromLentinus edodes: its application as a host defense potentiator.Intern. J. Orient. Med.,17, 57-77 (1992).
20. Maeda, Y. Y. and Chihara, G., Lentinan and other antitumoral polysaccharides. In “Immunomodulatory Agents Plants” Eds. Wagner, H., Birkhaeuser, Basel, Switz pp. 203-221 (1999).
21. Tsukagoshi, S., Hashimoto, Y., Fujii, G., Kobayashi, H., Nomoto, K., and Orita, K., Krestin (PSK).Cancer Treat. Rev.,11, 131-155 (1984).
22. Zhang, P., Zhang, L., and Cheng, S., Solution properties of a-(1→3)-D-glucan fromLentinus edodesand its sulfated derivatives.Carbohydr. Res.,337, 155-160 (2002).
23. Zhang, L., Zhang, M., Zhou, Q., Chen, J., and Zeng, F., Solution properties of antitumor sulfated derivative of a-(1→3)-D-glucan fromGanoderma lucidum. Biosci. Biotechnol. Biochem.,64, 2172-2178 (2000).
24. Harada, M., Matsunaga, K., Oguchi, Y., Iuima, H., Tamada, K., Abe, K., Takenoyama, M., Ito, O., Kimura, G., and Nomoto, K., Oral administration of PSK can improve the impaired anti-tumor CD4 + T-cell response in gut-associated lymphoid tissue (GALT) of specific-pathogen-free mice.Int. J. Cancer,70, 362-372 (1997).
25. Takeda, Y., Tanaka, M., Miyazaki, H., Takeo, S., Nomoto, K., and Yoshikai, Y., Analysis of effector T cells against the murine syngeneic tumor Meth A in mice orally administered antitumor polysaccharide SPR-901.Cancer Immunol. Immunother,38, 143-148 (1994).
26. Suzuki, I., Hashimoto, K., Ohno, N., Tanaka, H., and Yadomae, T., Immunomodulation by orally administered b-glucan in mice.Int. J. Immunophar-macol,11, 761-769 (1989).
27. Yamashita, A., Ohtsuka, H., and Maeda, H., Intestinal absorption and urinary excretion of antitumor peptidomannan KS-2 after oral administration in rats.Immunopharmacology,5, 209-220 (1983).
28. Nakahara, W., Tokuzen, R., Fukuoka, F., and Whistler, R. L., Inhibition of mouse sarcoma 180 by a wheat hemicellulose B preparation.Nature,216, 374-375 (1967).
29. Hamuro, J. and Chihara, G., Effect of antitumor polysaccharides on the higher structure of serum protein.Nature,245, 40-41 (1973).
30. Maeda, Y. Y., Chihara, G., and Ishimura, K., Unique increase of serum proteins and action of antitumor polysaccharides.Nature, 252, 250-252 (1974).
31. Ambrose E. J., James, A. M., and Lowick, L. H. B., Differences between the electrical change carried by normal and homologous tumour cells.Nature, 177, 576-577 (1956).
32. Liu, J. M., Haroun-Bouhedja, F., and Boisson-Vidal, C., Analysis of the in vitro inhibition of mammary adenocarcinoma cell adhesion by sulfated polysaccharides.Anticancer Res.,20, 3265-3271 (2000).